Evaluation of clinical efficacy and tolerability of intravenous high dose thymopentin in advanced melanoma patients.

Cascinelli, N

Evaluation of clinical efficacy and tolerability of intravenous high dose thymopentin in advanced melanoma patients. [electronic resource] - Melanoma research Feb 1998 - 83-9 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0960-8931

10.1097/00008390-199802000-00014 doi


Adjuvants, Immunologic--administration & dosage
Adult
Aged
Female
Humans
Immunophenotyping
Injections, Intravenous
Lymphocytes, Tumor-Infiltrating--pathology
Male
Melanoma--immunology
Middle Aged
Skin Neoplasms--immunology
Survival Rate
Thymopentin--administration & dosage
Treatment Outcome